8 completed. 8 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
| Phase 2 | 6 | Completed 6 |
Follow Urinary Calculi: new trials by email Literature Review of Urinary Calculi trials Research Report on Urinary Calculi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Silodosin in Management of Lower Ureteral Stones Silodosin - Stone, Kidney | Phase 1 / Phase 2 | Completed | Syrian Private University | 100 | 2022-10-20 | 2024-04-24 |
| Pramipexole and Morphine for Renal Colic Pramipexole, Morphine, Placebo oral tablet - Renal Colic | Phase 1 / Phase 2 | Completed | East Carolina University | 19 | 2019-10-28 | 2023-03-08 |
| Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study Tolvaptan, Placebo - Nephrolithiasis, Calcium Oxalate, Nephrolithiasis, Calcium Phosphate | Phase 1 | Completed | Mayo Clinic | 20 | 2014-03-01 | 2016-03-30 |
| Use of Lapis Judaicus to Dissolve Kidney Stones Lapis Judaicus, Placebo - Kidney Calculi | Phase 1 / Phase 2 | Completed | Shiraz University of Medical Sciences | 60 | 2011-01-01 | 2013-12-02 |
| Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones OMS201, Vehicle - Urinary Calculi, Urinary Stones | Phase 1 / Phase 2 | Completed | Omeros Corporation | 18 | 2009-03-01 | 2012-10-12 |
| Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones OMS201, Vehicle - Urinary Calculi, Urinary Stones | Phase 1 | Completed | Omeros Corporation | 11 | 2007-12-01 | 2010-04-30 |
| Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones Cystone, Sugar Pill (Placebo) - Cystinuria, Nephrolithiasis, Calcium Oxalate | Phase 1 / Phase 2 | Completed | Mayo Clinic | 20 | 2006-04-01 | 2016-02-04 |
| Use of Oral Probiotics to Reduce Urinary Oxalate Excretion Oxadrop, Agri-King Synbiotic (AKSB), Placebo - Nephrolithiasis, Hyperoxaluria | Phase 1 / Phase 2 | Completed | Mayo Clinic | 40 | 2006-02-01 | 2012-05-31 |
Kidney Calculi (7) · Calculi (3) · Nephrolithiasis (3) · Nephrolithiasis, Calcium Oxalate (2) · Agnosia (1) · Crohn Disease (1) · Cystinuria (1) · Hyperoxaluria (1) · Renal Colic (1)
Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Male Urogenital Diseases (8) · Pathological Conditions, Anatomical (8) · Pathological Conditions, Signs and Symptoms (8) · Urogenital Diseases (8) · Urolithiasis (8) · Urologic Diseases (8) · Kidney Diseases (7) · Calculi (5) · Nephrolithiasis (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Gastroenteritis (1)
Morphine (1) · Pramipexole (1) · Sugars (1) · Tolvaptan (1) · cystone (1) · silodosin (1)
Mayo Clinic (3) · Omeros Corporation (2) · East Carolina University (1) · Shiraz University of Medical Sciences (1) · Syrian Private University (1)
United States (6) · Iran (1) · Syria (1)
Jamshid Roozbeh, MD (1) · John C Lieske, MD (1) · John Lieske, MD (1) · Kori Brewer, PhD (1) · Scott Houston (1) · Stephen B. Erickson, M.D. (1)
PMID 20736987, PMID 21161651, PMID 21419606, PMID 39411383
P50DK083007 (2), R21AT002534 (1), UL1RR024150 (1)